https://www.fda.gov/medical-devices/in-vitro-diagnostics/precision-medicineThe FDA likes the idea of precision medicine
in relation to the use of next gen sequencing tests in identifying the right patients at the right time for treatments and/or drugs. The use of tight filters (disc lesions and time period of pain symptoms etc)) in identifying patients for the CLBP trial looks remarkably similar in concept to precision medicine to me.
Any thoughts, @benelong?
”The goal of precision medicine is to target the right treatments to the right patients at the right time.”
NASDAQ hot!!!, page-222
-
- There are more pages in this discussion • 460 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |